How to Read a Peptide Certificate of Analysis
A Certificate of Analysis is the document a laboratory issues alongside an analytical result set for a specific lot of material. This guide walks through each section of a typical peptide COA — identity, purity, mass confirmation, and administrative metadata — so a research buyer can evaluate what the document does and does not demonstrate.
What a Certificate of Analysis Is (and Isn't)
A Certificate of Analysis (COA) is a report generated by a testing laboratory summarizing the results of one or more analytical procedures performed on a specific sample of material. In the research peptide context, a COA is typically produced by an independent third-party laboratory that receives a sample drawn from a defined lot and returns data describing that sample's identity, purity, and related characteristics.
It is important to understand what a COA represents: a snapshot of a specific sample, tested by specific methods, at a specific point in time. It is not a guarantee about every vial in a shipment, nor is it a regulatory approval, a safety clearance, or a statement of fitness for any particular use. Reading a COA critically means understanding which claims the document actually supports and which it does not.
Header and Administrative Fields
Most COAs open with identifying information: the compound name, lot or batch number, the date the sample was received by the testing laboratory, and the date the report was issued. This metadata matters because it ties the analytical data to a specific, traceable production run rather than to the product line in general.
- Compound name and any synonym or catalog reference
- Lot/batch number — the traceability key linking the report to a manufacturing run
- Date sample received and date report issued
- Name and, where disclosed, accreditation status of the testing laboratory
Identity Confirmation
Identity testing answers a single question: is the molecule in the vial the molecule it is labeled as? For peptides, identity is commonly established using mass spectrometry (MS), which measures the molecular weight of the sample and compares it to the theoretical or expected molecular weight of the target sequence. A close match between observed and expected mass supports — though does not by itself fully prove — correct identity.
Some COAs will also reference amino acid sequence confirmation or other structural techniques. Where a report lists only a single confirmatory method, it is reasonable for a researcher to treat that as a starting point for further in-house verification rather than an exhaustive identity determination.
Purity Data and Chromatograms
The purity section is usually generated using High-Performance Liquid Chromatography (HPLC), sometimes paired with Ultra-High-Performance Liquid Chromatography (UHPLC). These techniques separate the components of a sample as it passes through a column, producing a chromatogram — a plot of detector response over time. Each peak on the chromatogram corresponds to a distinct component eluting at a distinct retention time.
Purity is generally expressed as an area-percentage value: the area under the main peak divided by the total area under all peaks, expressed as a percentage. A well-prepared COA will show the chromatogram itself, not just a summary number, along with the column type, mobile phase, and detection wavelength used. This allows a reader with chromatography experience to evaluate peak shape, baseline resolution, and whether minor peaks were reasonably excluded or included in the calculation.
Related but distinct is the concept of analytical validation, described in guidance frameworks such as ICH Q2(R2) and general chapters like USP <1225> on validation of compendial procedures. These frameworks describe how a laboratory should demonstrate that its method reliably measures what it claims to measure — for example, through parameters such as specificity, linearity, and precision — rather than describing the purity of any single sample. A COA that references a validated method is communicating that the underlying test procedure has documented performance characteristics, which is a different statement than the purity result itself.
Supplementary Testing
Depending on the laboratory and the compound, a COA may include additional panels such as residual solvent analysis, endotoxin testing, heavy metals screening, or microbial testing. Each of these addresses a different quality dimension and uses its own dedicated method — for instance, endotoxin testing commonly uses a Limulus Amebocyte Lysate (LAL)-based assay. Not every COA includes every panel, and a research buyer should read the document to see exactly which tests were run rather than assuming a standard panel was applied.
Reading a COA Critically
A useful habit is to check that the lot number on the COA matches the lot number printed on the vial or product label in hand — a COA for the wrong lot provides no meaningful assurance about the material actually received. It is also worth checking that the testing laboratory is named and, ideally, independently identifiable, and that the document discloses the methods used rather than presenting only a final percentage.
Finally, remember that a COA describes analytical characteristics of a sample intended for laboratory research use. It does not constitute or imply any claim about safety, efficacy, or suitability for human or animal administration, and none of the material discussed here should be interpreted as guidance for such use.